Skip to content

BIOCEPT, INC.: 10-K filed 2016-03-10

What BIOCEPT, INC. reported in its annual report filed 2016-03-10 (fiscal FY 2015): 40 published measures, 181 facts as tagged in accession 0001564590-16-014436.

This filing

Form
10-K (annual report)
Filed
2016-03-10
Fiscal period
fiscal FY 2015
Accession
0001564590-16-014436 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIOCEPT, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-12-3110,586,918USD
At 2015-09-3014,196,386USD
At 2015-06-3018,317,659USD
At 2015-03-3120,899,513USD
At 2014-12-316,565,053USD
At 2014-09-309,849,674USD
At 2014-06-3013,332,475USD
At 2014-03-3111,289,508USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-12-316,894,183USD
At 2014-12-316,785,622USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-12-313,692,735USD
At 2015-09-306,928,277USD
At 2015-06-3011,049,961USD
At 2015-03-3113,582,795USD
At 2014-12-31-220,569USD
At 2014-09-303,319,532USD
At 2014-06-306,855,762USD
At 2014-03-319,356,778USD
At 2013-12-31-12,456,014USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-12-318,821,329USD
At 2015-09-3012,541,919USD
At 2015-06-3016,523,975USD
At 2015-03-3119,294,706USD
At 2014-12-315,364,582USD
At 2014-09-308,819,872USD
At 2014-06-3012,460,565USD
At 2014-03-3110,417,277USD
At 2013-12-3169,178USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-4,617,500USD92
2015-01-01 to 2015-12-31-16,949,526USD365
2015-07-01 to 2015-09-30-4,496,193USD92
2015-04-01 to 2015-06-30-4,035,105USD91
2015-01-01 to 2015-03-31-3,800,728USD90
2014-10-01 to 2014-12-31-3,881,541USD92
2014-01-01 to 2014-12-31-15,866,046USD365
2014-07-01 to 2014-09-30-3,859,794USD92
2014-04-01 to 2014-06-30-2,996,840USD91
2014-01-01 to 2014-03-31-5,127,871USD90

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-12-31165,160USD365
2014-01-01 to 2014-12-31394,925USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-10-01 to 2015-12-31218,283USD92
2015-01-01 to 2015-12-31609,909USD365
2015-07-01 to 2015-09-30164,856USD92
2015-04-01 to 2015-06-3076,768USD91
2015-01-01 to 2015-03-31150,002USD90
2014-10-01 to 2014-12-3175,621USD92
2014-01-01 to 2014-12-31133,415USD365
2014-07-01 to 2014-09-3010,274USD92
2014-04-01 to 2014-06-3019,245USD91
2014-01-01 to 2014-03-3128,275USD90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-12-31-155,236,548USD
At 2014-12-31-138,287,022USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2015-10-01 to 2015-12-3118,921,945shares92
2015-01-01 to 2015-12-3116,538,963shares365
2015-07-01 to 2015-09-3018,727,806shares92
2015-04-01 to 2015-06-3017,998,969shares91
2015-01-01 to 2015-03-3110,372,667shares90
2014-10-01 to 2014-12-314,449,603shares92
2014-01-01 to 2014-12-313,997,797shares365
2014-07-01 to 2014-09-304,449,603shares92
2014-04-01 to 2014-06-304,449,603shares91
2014-01-01 to 2014-03-312,617,275shares90

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2015-10-01 to 2015-12-3118,921,945shares92
2015-01-01 to 2015-12-3116,538,963shares365
2015-07-01 to 2015-09-3018,727,806shares92
2015-04-01 to 2015-06-3017,998,969shares91
2015-01-01 to 2015-03-3110,372,667shares90
2014-10-01 to 2014-12-314,449,603shares92
2014-01-01 to 2014-12-313,997,797shares365
2014-07-01 to 2014-09-304,449,603shares92
2014-04-01 to 2014-06-304,449,603shares91
2014-01-01 to 2014-03-312,617,275shares90

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-0.24USD/shares92
2015-01-01 to 2015-12-31-1.02USD/shares365
2015-07-01 to 2015-09-30-0.24USD/shares92
2015-04-01 to 2015-06-30-0.22USD/shares91
2015-01-01 to 2015-03-31-0.37USD/shares90
2014-10-01 to 2014-12-31-0.87USD/shares92
2014-01-01 to 2014-12-31-3.97USD/shares365
2014-07-01 to 2014-09-30-0.87USD/shares92
2014-04-01 to 2014-06-30-0.67USD/shares91
2014-01-01 to 2014-03-31-1.96USD/shares90

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-0.24USD/shares92
2015-01-01 to 2015-12-31-1.02USD/shares365
2015-07-01 to 2015-09-30-0.24USD/shares92
2015-04-01 to 2015-06-30-0.22USD/shares91
2015-01-01 to 2015-03-31-0.37USD/shares90
2014-10-01 to 2014-12-31-0.87USD/shares92
2014-01-01 to 2014-12-31-3.97USD/shares365
2014-07-01 to 2014-09-30-0.87USD/shares92
2014-04-01 to 2014-06-30-0.67USD/shares91
2014-01-01 to 2014-03-31-1.96USD/shares90

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-01-01 to 2015-12-311,608USD365
2014-01-01 to 2014-12-311,506USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-12-31946,180USD
At 2014-12-31662,422USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-12-311,377,824USD365
2014-01-01 to 2014-12-311,822,661USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-10-01 to 2015-12-31-4,510,470USD92
2015-01-01 to 2015-12-31-16,410,803USD365
2015-07-01 to 2015-09-30-4,358,844USD92
2015-04-01 to 2015-06-30-3,890,884USD91
2015-01-01 to 2015-03-31-3,650,605USD90
2014-10-01 to 2014-12-31-3,731,259USD92
2014-01-01 to 2014-12-31-13,873,924USD365
2014-07-01 to 2014-09-30-3,711,629USD92
2014-04-01 to 2014-06-30-2,904,013USD91
2014-01-01 to 2014-03-31-3,527,023USD90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-12-319,640,738USD
At 2014-12-315,902,631USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-01-01 to 2015-12-31640,478USD365
2014-01-01 to 2014-12-311,789,680USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-12-313,340,788USD
At 2014-12-311,430,783USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-12-31632,538USD
At 2014-12-31641,406USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-12-3134,200USD
At 2014-12-3110,600USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-12-31349,271USD
At 2014-12-31188,728USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2015-10-01 to 2015-12-311,275,691USD92
2015-01-01 to 2015-12-314,596,158USD365
2015-07-01 to 2015-09-301,159,710USD92
2015-04-01 to 2015-06-301,013,075USD91
2015-01-01 to 2015-03-311,147,682USD90
2014-10-01 to 2014-12-31614,688USD92
2014-01-01 to 2014-12-312,170,548USD365
2014-07-01 to 2014-09-30538,181USD92
2014-04-01 to 2014-06-30359,364USD91
2014-01-01 to 2014-03-31658,315USD90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-10-01 to 2015-12-31784,379USD92
2015-01-01 to 2015-12-312,857,770USD365
2015-07-01 to 2015-09-30677,729USD92
2015-04-01 to 2015-06-30744,242USD91
2015-01-01 to 2015-03-31651,420USD90
2014-10-01 to 2014-12-311,070,278USD92
2014-01-01 to 2014-12-314,497,790USD365
2014-07-01 to 2014-09-301,310,905USD92
2014-04-01 to 2014-06-301,107,678USD91
2014-01-01 to 2014-03-311,008,929USD90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-12-3119,670,054shares
At 2014-12-314,449,603shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-12-314,739,390USD
At 2014-12-315,270,602USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-12-313,793,210USD
At 2014-12-314,608,180USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-12-31966,899USD
At 2014-12-31699,903USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-12-31435,938USD
At 2014-12-31338,721USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-16,947,918USD365
2014-01-01 to 2014-12-31-15,864,540USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-10-01 to 2015-12-311,404,515USD92
2015-01-01 to 2015-12-315,686,398USD365
2015-07-01 to 2015-09-301,630,608USD92
2015-04-01 to 2015-06-301,359,226USD91
2015-01-01 to 2015-03-311,292,049USD90
2014-10-01 to 2014-12-311,231,418USD92
2014-01-01 to 2014-12-315,201,997USD365
2014-07-01 to 2014-09-301,060,812USD92
2014-04-01 to 2014-06-301,032,855USD91
2014-01-01 to 2014-03-311,876,912USD90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-01-01 to 2015-12-31261,000USD365
2014-01-01 to 2014-12-31251,000USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-537,115USD365
2014-01-01 to 2014-12-31-1,990,616USD365

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2015-01-01 to 2015-12-311,608USD365
2014-01-01 to 2014-12-311,506USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2015-01-01 to 2015-12-31405,715USD365
2014-01-01 to 2014-12-31402,075USD365

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2015-01-01 to 2015-12-312,184USD365
2014-01-01 to 2014-12-31800USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-01-01 to 2015-12-319,788,057USD365
2015-02-12 to 2015-02-13177,500USD2
2014-01-01 to 2014-12-3117,390,240USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-12-3123,600USD365
2014-01-01 to 2014-12-311,400USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-12-31126,106USD365
2014-01-01 to 2014-12-3182,126USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-12-31-51,790USD365
2014-01-01 to 2014-12-31-981,869USD365

Inspect the source

Entity
BIOCEPT, INC. / CIK 0001044378
Captured
SEC response SHA-256
e2cd33a1599dddaf1c1158b0c135422459c9498a550077875151b7dd6db64b15

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001044378.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))